Abstract
Although re-activating cytotoxic T-cell (CTLs) response inside tumor tissues by checkpoint blockade has demonstrated great success in tumor immunotherapy, active induction of efficient endogenous CTL response by therapeutic vaccines has been largely hampered by inefficient cytosolic delivery of antigens and coordinated activation of dendritic cells (DCs) in lymph nodes. Here we show that polyethylene glycol-phosphatidylethanolamine (PEG-PE) micelles transform soluble peptides into α-helix to enable their efficient cytosolic delivery. The same PEG-PE micelles also serve as chaperon of TLR4 signaling to coordinate its adjuvant effect on the same DCs. Furthermore, these nanovaccines effectively target lymph node DCs. Thus, PEG-PE micelle vaccines program at multiple key aspects for inducing strong CTL responses and build up a foundation for combinational tumor therapy.
Highlights
The importance of cytotoxic T-lymphocyte (CTL) response has been increasingly acknowledged in a series of tumor therapeutic approaches, such as chemotherapy, radiation therapy, antibody mediated targeting therapy and so on [1,2,3,4]
Cytosolic delivery of antigen is favorable for CTL priming through cross-presentation pathway
We have found polyethylene glycol (PEG)-PE micelles is an efficient carrier for cytosolic delivery of antigen peptide
Summary
The importance of cytotoxic T-lymphocyte (CTL) response has been increasingly acknowledged in a series of tumor therapeutic approaches, such as chemotherapy, radiation therapy, antibody mediated targeting therapy and so on [1,2,3,4]. It has been further exemplified with recent great success of checkpoint blockade [5, 6]. Many soluble antigenic peptides are non-alpha-helix [17]. For this type of antigens, it is challenging to transform them into α-helix for efficient cytosolic delivery
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.